Healthcare Archives - Page 5 of 18 - Bryan, Garnier & Co

Bryan, Garnier & Co acts as Joint Bookrunner on Valneva’s Nasdaq & Euronext Paris USD 102m Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on its acquisition of STAR Teams, and as Joint Global Coordinator on subsequent SEK 250 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to Cleerly on its USD 43 million Series B Fundraising

Bryan, Garnier & Co acts as Joint Bookrunner on BICO’s SEK 2 billion Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of CanPharma GmbH on the sale of the company to Health House International Ltd (ASX:HHI)

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on Heidelberg Pharma’s EUR 20 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to FCDE on its acquisition of a majority stake in Didactic alongside its management team

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Abivax’s EUR 85 million Follow-on Offering & Convertible Bonds Issuance

Bryan, Garnier & Co advises Halma on its acquisition of PeriGen

Bryan, Garnier & Co acts as Joint Bookrunner to Valneva on its USD 108 million Nasdaq Initial Public Offering

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }